Microba Life Sciences Ltd (MAP) — Financial Flexibility Index
Microba Life Sciences Ltd (MAP) has a Financial Flexibility Index of -0.45x as of December 2025. Free cash flow of AU$-5.51 Million (operating CF AU$-5.70 Million minus capex AU$189.71K) represents 0% of total liabilities (AU$12.27 Million). Check MAP strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Microba Life Sciences Ltd Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Microba Life Sciences Ltd across 7 annual periods. See Microba Life Sciences Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Microba Life Sciences Ltd (2018–2024)
Year-by-year free cash flow to debt coverage for Microba Life Sciences Ltd. For the full company profile including market capitalisation, see how much is Microba Life Sciences Ltd worth.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.61x | AU$-9.11 Million | AU$-12.01 Million | AU$14.94 Million | ▲ +8.3% |
| 2023 | -0.66x | AU$-11.19 Million | AU$-15.57 Million | AU$16.82 Million | ▲ +41.5% |
| 2022 | -1.14x | AU$-9.36 Million | AU$-12.39 Million | AU$8.23 Million | ▲ +21.2% |
| 2021 | -1.44x | AU$-8.58 Million | AU$-10.45 Million | AU$5.94 Million | ▲ +21.3% |
| 2020 | -1.83x | AU$-6.51 Million | AU$-7.18 Million | AU$3.55 Million | ▼ -64.1% |
| 2019 | -1.12x | AU$-3.47 Million | AU$-4.32 Million | AU$3.10 Million | ▲ +42.5% |
| 2018 | -1.94x | AU$-2.78 Million | AU$-3.62 Million | AU$1.43 Million | — |